NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP
· Real-Time Price · USD
2.00
-0.12 (-5.66%)
At close: Oct 03, 2025, 3:59 PM
1.98
-0.75%
After-hours: Oct 03, 2025, 07:41 PM EDT
-5.66% (1D)
| Bid | 1.97 |
| Market Cap | 6.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.98M |
| EPS (ttm) | -2.63 |
| PE Ratio (ttm) | -0.76 |
| Forward PE | 0.05 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 2.06 |
| Volume | 241,294 |
| Avg. Volume (20D) | 422,088 |
| Open | 2.13 |
| Previous Close | 2.12 |
| Day's Range | 1.97 - 2.13 |
| 52-Week Range | 1.30 - 5.64 |
| Beta | 0.13 |
| Ex-Dividend Date | n/a |
About NLSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NLSP
Website n/a
1 month ago
-12.65%
NLS Pharmaceutics shares are trading lower after t...
Unlock content with
Pro Subscription
3 months ago
+3.94%
NLSP stock has given up its prior gain. NLS Pharmaceutics shares were trading higher after the company announced it completed its second and final equity financing round consisting of preferred shares and warrants worth $3 million in total.
